Cardiac Injury and Outcomes of Patients With COVID-19 in New York City

Tetsuro Maeda1, Reiichiro Obata1, Dahlia Rizk1

  • 1Department of Medicine, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, NY, USA.

Heart, Lung & Circulation
|December 6, 2020
PubMed

Insights

Elevated troponin in COVID-19 patients indicates cardiac injury and is linked to higher in-hospital mortality, even without typical ECG changes. This cardiac injury is an independent predictor of mortality.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Elevated troponin levels in COVID-19 patients correlate with increased in-hospital mortality.
  • The relationship between cardiac injury, electrocardiogram (ECG) abnormalities, and mortality in COVID-19 patients requires further investigation.

Purpose of the Study:

  • To examine the association between cardiac injury (elevated troponin I) and ECG abnormalities in hospitalized COVID-19 patients.
  • To determine if cardiac injury is an independent predictor of in-hospital mortality in this population.

Main Methods:

  • Retrospective cohort study of 181 patients hospitalized with COVID-19.
  • Patients were categorized into cardiac injury (elevated troponin I) and no cardiac injury groups.
  • Multivariate logistic regression analysis was used to identify predictors of in-hospital mortality.

Main Results:

  • The cardiac injury group (n=54) showed higher rates of older age, cardiovascular comorbidities, and elevated inflammatory markers.
  • While numerically more frequent, ECG abnormalities like T wave inversion and ST depression were not statistically significant between groups.
  • In-hospital mortality was significantly higher in the cardiac injury group (42.3%) compared to the no cardiac injury group (12.6%).
  • Cardiac injury (OR 3.25) and age were independent predictors of in-hospital mortality.

Conclusions:

  • Hospitalized COVID-19 patients with elevated troponin I often present with minimal chest pain and infrequent ECG abnormalities.
  • Cardiac injury, indicated by elevated troponin I, is a significant independent predictor of in-hospital mortality in COVID-19 patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
106
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
84
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
191
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
210
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
268
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
371